A preliminary report on target organ genotoxicity biomonitoring by an "improved random amplified polymorphic DNA" assay

Abstract

Genetic changes, genotoxicity and even target organ genotoxicity can be monitored by using RAPD assays that have a great potential in detecting DNA effects as well as pathologic and/or physiologic ones, when as little as 2-5% of the cells have the same affected genotype.